Find out more about Sumitra Ananda's experience
Sumitra Ananda's highlights
Sumitra Ananda's selected work
Molecular correlates of platinum response in human high-grade serous ovarian cancer patien..
Utilisation of systemic therapy options in routine treatment of metastatic colorectal canc..
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilita..
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Thera..
Displaying the 35 most recent scholarly works by Sumitra Ananda.
Therapeutic options for mucinous ovarian carcinoma
Kylie L Gorringe, Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, David DL Bowtell, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Sian Fereday, C Blake Gilks, Charlie Gourley, Alison M Hadley, Joy Hendley, Sally M Hunter, Scott H Kaufmann, et al.
Journal article | 2020 | Gynecologic Oncology
OBJECTIVE: Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype that responds poorly to conventional chemother..
Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia
Rachel Delahunty, Margaret Lee, Hui-Li Wong, Julie Johns, Joseph Mckendrick, Belinda Lee, Suzanne Kosmider, Prasad Cooray, Sumitra Ananda, Jayesh Desai, Ben Tran, Jeanne Tie, Peter Gibbs, Rachel Wong
Journal article | 2020 | Internal Medicine Journal
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer Research.
Damien Kee, Clare Parker, Susie Bae, Katherine M Tucker, Michelle Harrison, Ibrahim Tohidi-Esfahani, Marita Black, Rachel Delahunty, Sumitra Ananda, Michael Friedlander, Heather E Cunliffe, Peter Gibbs, Jayesh Desai, Judith Trotman, Clare L Scott
Journal article | 2020 | JCO Clinical Cancer Informatics
PURPOSE: Rare cancers are challenging for researchers, as clinicians and scientists have difficulty recruiting sufficient patient ..
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Michael Christie, Koen Simons, Margaret Lee, Rachel Wong, Suzanne Kosmider, Sumitra Ananda, Joseph McKendrick, Belinda Lee, Jin Hee Cho, Ian Faragher, Ian T Jones, Janine Ptak, Mary J Schaeffer, Natalie Silliman, Lisa Dobbyn, Lu Li, Cristian Tomasetti, et al.
Journal article | 2019 | JAMA Oncology
Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual dise..
How can digital health be used to improve outcomes in pancreatic ductal adenocarcinoma (PDAC)? Examining the potential of the PURPLE translational pancreatic cancer platform
Belinda Lee, Julia Shapiro, Benjamin Thomson, Sumitra Ananda, Lara Lipton, Sue-Anne McLachlan, Rachel Wong, Prasad Cooray, Matthew Burge, Kate Clarke, Sharon Pattison, Mehrdad Nikfarjam, Niall Tebbutt, Marion Harris, Daniel Croagh, David Goldstein, Adnan Nagrial, Rob Zielinski, Amitesh Roy, Cheng Ean Chee, et al.
Conference Proceedings | 2019 | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
The molecular origin and taxonomy of mucinous ovarian carcinoma
Dane Cheasley, Matthew J Wakefield, Georgina L Ryland, Prue E Allan, Kathryn Alsop, Kaushalya C Amarasinghe, Sumitra Ananda, Michael S Anglesio, George Au-Yeung, Maret Bohm, David Dl Bowtell, Alison Brand, Georgia Chenevix-Trench, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Renee Demeo, Rhiannon Dudley, Nicole Fairweather, et al.
Journal article | 2019 | NATURE COMMUNICATIONS
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study
Olga Kondrashova, Gwo-Yaw Ho, George Au-Yeung, Leakhena Leas, Tiffany Boughtwood, Kathryn Alsop, Giada Zapparoli, Alexander Dobrovic, Yi-An Ko, Arthur L Hsu, Clare J Love, Sebastian Lunke, Matthew J Wakefield, Orla McNally, Michael Quinn, Sumitra Ananda, Deborah Neesham, Anne Hamilton, Marisa Grossi, Alison Freimund, et al.
Journal article | 2019 | JCO Precision Oncology
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival
Shehara Mendis, Sophie Beck, Belinda Lee, Margaret Lee, Rachel Wong, Suzanne Kosmider, Jeremy Shapiro, Desmond Yip, Simone Steel, Louise Nott, Ross Jennens, Lara Lipton, Matthew Burge, Kathryn Field, Sumitra Ananda, Hui-Li Wong, Peter Gibbs
Journal article | 2019 | Asia-Pacific Journal of Clinical Oncology
Use of folfirinox chemotherapy in an Australasian population of pancreatic cancer
A Jalali, M Lee, C Semira, S Banks, HL Wong, S Ananda, L Lipton, JD Shapiro, P Cooray, K Clarke, M Burge, R Wong, JA Shapiro, SA McLachlan, M Harris, D Croagh, N Tebbutt, P Gibbs, B Lee
Journal article | 2018 | Annals of Oncology
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Olga Kondrashova, Monique Topp, Ksenija Nesic, Elizabeth Lieschke, Gwo-Yaw Ho, Maria Harrell, Giada Zapparoli, Alison Hadley, Robert Holian, Emma Boehm, Valerie Heong, Elaine Sanij, Richard B Pearson, John J Krais, Neil Johnson, Orla McNally, Sumitra Ananda, Kathryn Alsop, Karla J Hutt, Scott H Kaufmann, et al.
Journal article | 2018 | NATURE COMMUNICATIONS
REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal (IP) bevacizumab (bev) for recurrent ascites in advanced, chemotherapy-resistant, epithelial ovarian cancer (CR-EOC).
Katrin Marie Sjoquist, Linda R Mileshkin, Sumitra Ananda, Catherine M Shannon, David Bowtell, Sonia Yip, David Espinoza, Jeffrey C Goh, Michelle L Harrison, Magdalena Plebanski, Val Gebski, Martin R Stockler, Karen Livingstone, Monica Tang, Michael Friedlander
Conference Proceedings | 2018 | Journal of Clinical Oncology
Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).
Jeanne Tie, Joshua Cohen, Yuxuan Wang, Margaret Lee, Rachel Wong, Suzanne Kosmider, Sumitra Ananda, Jin Hee Cho, Ian Faragher, Joseph James McKendrick, Carmela Corfield, Belinda Lee, Kathryn Maree Field, Ian Jones, Lu Li, Cristian Tomasetti, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Peter Gibbs
Conference Proceedings | 2018 | Journal of Clinical Oncology
Precision oncology using a clinician-directed, tailored approach to molecular profiling
Michael Lam, Ben Tran, Sophie Beck, Jeanne Tie, Dishan Herath, James Whittle, Edmond M Kwan, Stephen B Fox, Andrew Fellowes, Sumitra Ananda, Lara Lipton, Peter Gibbs, Mark A Rosenthal, Jayesh Desai
Journal article | 2018 | Asia-Pacific Journal of Clinical Oncology
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
Dale W Garsed, Kathryn Alsop, Sian Fereday, Catherine Emmanuel, Catherine J Kennedy, Dariush Etemadmoghadam, Bo Gao, Val Gebski, Valerie Gares, Elizabeth L Christie, Maartje CA Wouters, Katy Milne, Joshy George, Ann-Marie Patch, Jason Li, Gisela Mir Arnau, Timothy Semple, Sreeja R Gadipally, Yoke-Eng Chiew, Joy Hendley, et al.
Journal article | 2018 | Clinical Cancer Research
The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study
Belinda Lee, Hui-Li Wong, Mark Tacey, Jeanne Tie, Rachel Wong, Margaret Lee, Louise Nott, Jeremy Shapiro, Ross Jennens, Natalie Turner, Ben Tran, Sumitra Ananda, Desmond Yip, Gary Richardson, Phillip Parente, Lionel Lim, Greg Stefanou, Matthew Burge, Mahesh Iddawela, Jeremy Power, et al.
Journal article | 2017 | Asia-Pacific Journal of Clinical Oncology
Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott
Journal article | 2017 | Gynecologic Oncology
Frontline treatment of epithelial ovarian cancer.
Jeffrey Goh, G Raj Mohan, Rahul Ladwa, Sumitra Ananda, Paul A Cohen, Sally Baron-Hay
Journal article | 2015 | Asia-Pacific Journal of Clinical Oncology
This is a contemporaneous review of the frontline treatment of epithelial ovarian cancer (EOC), specifically on the importance of ..
Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice
K Field, J Shapiro, H-L Wong, M Tacey, L Nott, B Tran, N Turner, S Ananda, G Richardson, R Jennens, R Wong, J Power, M Burge, P Gibbs
Journal article | 2015 | Internal Medicine Journal
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer.
Ignace Vergote, Russell J Schilder, Charles H Pippitt, Shirley Wong, Alan N Gordon, Sidney Scudder, Frederic Kridelka, Luc Dirix, Joseph W Leach, Sumitra Ananda, Nuwan Nanayakkara, Rebeca Melara, Michael B Bass, Jason Litten, Henry Adewoye, Robert M Wenham
Journal article | 2014 | Gynecologic Oncology
OBJECTIVE: To examine the tolerability and antitumor activity of trebananib plus pegylated liposomal doxorubicin (PLD) or topoteca..
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
Monique D Topp, Lynne Hartley, Michele Cook, Valerie Heong, Emma Boehm, Lauren McShane, Jan Pyman, Orla McNally, Sumitra Ananda, Marisol Harrell, Dariush Etemadmoghadam, Laura Galletta, Kathryn Alsop, Gillian Mitchell, Stephen B Fox, Jeffrey B Kerr, Karla J Hutt, Scott H Kaufmann, Elizabeth M Swisher, David D Bowtell, et al.
Journal article | 2014 | Molecular Oncology
Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy.
Mustafa Khasraw, Saw Yee Yap, Sumitra Ananda
Journal article | 2013 | Expert Review of Anticancer Therapy
Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of neoplasms derived from peptide- and amine-secreting cells of the..
Individualisation of the systemic biologic therapy for advanced colorectal cancer: Light beyond K-ras status
S Ananda, M Michael
Book Chapter | 2012 | International Journal of Cancer Prevention
Metastatic colorectal cancer (CRC) is one of the most common malignancies in the Western world. The number of active anti-cancer a..
Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data
B Tran, CL Keating, SS Ananda, S Kosmider, I Jones, M Croxford, KM Field, RC Carter, P Gibbs
Journal article | 2012 | Internal Medicine Journal
Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy
Sumitra Ananda, Anna K Nowak, Lawrence Cher, Anthony Dowling, Chris Brown, John Simes, Mark A Rosenthal
Journal article | 2011 | Journal of Clinical Neuroscience
Initial impact of Australia's National Bowel Cancer Screening Program
Sumitra S Ananda, Stephen J McLaughlin, Frank Chen, Ian P Hayes, Andrew A Hunter, Iain J Skinner, Malcolm CA Steel, Ian T Jones, Ian A Hastie, Nicholas A Rieger, Susan Shedda, Daniel J Compston, Peter Gibbs
Journal article | 2009 | Medical Journal of Australia
Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice
Sumitra Ananda, Kathryn M Field, Suzanne Kosmider, Daniel Compston, Jayesh Desai, Lionel C Lim, Frances S Barnett, Ian T Jones, Iain Skinner, Peter Gibbs
Journal article | 2008 | Journal of Clinical Oncology